Uncategorized
Pixium Vision releases 6-month update of Iris II epiretinal system
Pixium Vision’s epiretinal Iris II system for outer retinal degeneration improves visual performance after 6 months, but a shorter device lifespan has been detected, according to a press release.Clinical safety and performance data at 6 months demonstrated the device had a favorable safety profile, the release said. However, new implantations have been temporarily halted while the company validates corrective measures with regulatory bodies regarding the lifespan of the Iris II system.